Q2 2025 Holdings
Filed 2025-08-14 | 72 holdings | $1.1B | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Insmed Inc(INSM) | COM PAR $.01 | 457669307 | $161.0M | 1,600,000 | 14.7% |
| Boston Scientific Corp(BSX) | COM | 101137107 | $59.1M | 550,000 | 5.4% |
| Tenet Healthcare Corp(THC) | COM NEW | 88033G407 | $48.4M | 275,000 | 4.4% |
| Encompass Health Corp(EHC) | COM | 29261A100 | $39.2M | 320,000 | 3.6% |
| Mineralys Therapeutics Inc(MLYS) | COM | 603170101 | $36.5M | 2,700,000 | 3.3% |
| Cytokinetics Inc(CYTK) | COM NEW | 23282W605 | $33.0M | 1,000,000 | 3.0% |
| Brightspring Health Svcs Inc(BTSG) | COM | 10950A106 | $29.5M | 1,250,000 | 2.7% |
| Vera Therapeutics Inc(VERA) | CL A | 92337R101 | $27.1M | 1,150,000 | 2.5% |
| Quest Diagnostics Inc(DGX) | COM | 74834L100 | $26.9M | 150,000 | 2.5% |
| Regeneron Pharmaceuticals(REGN) | COM | 75886F107 | $26.3M | 50,000 | 2.4% |
| Novartis AG(NVSN) | SPONSORED ADR | 66987V109 | $24.2M | 200,000 | 2.2% |
| Cardinal Health Inc(CAH) | COM | 14149Y108 | $23.5M | 140,000 | 2.2% |
| Elevance Health Inc(ELV) | COM | 036752103 | $23.3M | 60,000 | 2.1% |
| Radnet Inc(RDNT) | COM | 750491102 | $22.8M | 400,000 | 2.1% |
| Fresenius Medical Care AG(FMS) | SPONSORED ADR | 358029106 | $21.4M | 750,000 | 2.0% |
| ELI Lilly & Co(LLY) | COM | 532457108 | $19.5M | 25,000 | 1.8% |
| Neurocrine Biosciences Inc(NBIX) | COM | 64125C109 | $18.9M | 150,000 | 1.7% |
| Uniqure NV(QURE) | SHS | N90064101 | $18.8M | 1,350,000 | 1.7% |
| Alnylam Pharmaceuticals Inc(ALNY) | COM | 02043Q107 | $17.9M | 55,000 | 1.6% |
| Dexcom Inc(DXCM) | COM | 252131107 | $17.5M | 200,000 | 1.6% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $17.4M | 115,000 | 1.6% |
| Medtronic PLC(MDT) | SHS | G5960L103 | $17.4M | 200,000 | 1.6% |
| CVS Health Corp(CVS) | COM | 126650100 | $17.2M | 250,000 | 1.6% |
| Pfizer Inc(PFE) | COM | 717081103 | $17.0M | 700,000 | 1.6% |
| Cytokinetics Inc(CYTK)Call | COM NEW | 23282W605 | $16.5M | 500,000 | 1.5% |
| Edwards Lifesciences Corp(EW) | COM | 28176E108 | $15.6M | 200,000 | 1.4% |
| GE Healthcare Technologies I(GEHC) | COMMON STOCK | 36266G107 | $14.8M | 200,000 | 1.4% |
| Astrazeneca PLC(AZN) | SPONSORED ADR | 046353108 | $14.0M | 200,000 | 1.3% |
| Edgewise Therapeutics Inc(EWTX) | COM | 28036F105 | $13.1M | 1,000,000 | 1.2% |
| Oric Pharmaceuticals Inc(ORIC) | COM | 68622P109 | $12.7M | 1,250,000 | 1.2% |
| Revolution Medicines Inc(RVMD) | COM | 76155X100 | $12.0M | 325,000 | 1.1% |
| 89Bio Inc(ETNBGBP) | COM | 282559103 | $10.3M | 1,050,000 | 0.9% |
| Penumbra Inc(PEN) | COM | 70975L107 | $10.3M | 40,000 | 0.9% |
| Moonlake Immunotherapeutics(MLTX) | CLASS A ORD | 61559X104 | $9.4M | 200,000 | 0.9% |
| Inspire MED SYS Inc(INSP) | COM | 457730109 | $9.1M | 70,000 | 0.8% |
| Acadia Healthcare Company in(ACHC) | COM | 00404A109 | $9.1M | 400,000 | 0.8% |
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $8.5M | 500,000 | 0.8% |
| Hologic Inc(HOLX) | COM | 436440101 | $8.1M | 125,000 | 0.7% |
| Tarsus Pharmaceuticals Inc(TARS) | COM | 87650L103 | $8.1M | 200,000 | 0.7% |
| Rezolute Inc(RZLT) | COM NEW | 76200L309 | $8.0M | 1,800,000 | 0.7% |
| Rhythm Pharmaceuticals Inc(RYTM) | COM | 76243J105 | $7.6M | 120,000 | 0.7% |
| Baxter Intl Inc(BAX) | COM | 071813109 | $7.6M | 250,000 | 0.7% |
| Abbvie Inc(ABBV) | COM | 00287Y109 | $7.4M | 40,000 | 0.7% |
| Mckesson Corp(MCK) | COM | 58155Q103 | $7.3M | 10,000 | 0.7% |
| Roivant Sciences LTD(ROIV) | SHS | G76279101 | $6.8M | 600,000 | 0.6% |
| Irhythm Technologies Inc(IRTC) | COM | 450056106 | $6.2M | 40,000 | 0.6% |
| Agilent Technologies Inc(A) | COM | 00846U101 | $5.9M | 50,000 | 0.5% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $5.7M | 700,000 | 0.5% |
| Verona Pharma PLC(VRNA) | SPONSORED ADS | 925050106 | $5.7M | 60,000 | 0.5% |
| Alignment Healthcare Inc(ALHC) | COM | 01625V104 | $5.6M | 400,000 | 0.5% |